Logo image of MSBI

MIDLAND STATES BANCORP INC (MSBI) Stock Fundamental Analysis

NASDAQ:MSBI - Nasdaq - US5977421057 - Common Stock - Currency: USD

16.94  -0.03 (-0.18%)

After market: 16.94 0 (0%)

Fundamental Rating

3

Taking everything into account, MSBI scores 3 out of 10 in our fundamental rating. MSBI was compared to 395 industry peers in the Banks industry. MSBI may be in some trouble as it scores bad on both profitability and health. MSBI is valued correctly, but it does not seem to be growing. Finally MSBI also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

MSBI had negative earnings in the past year.
MSBI had a positive operating cash flow in the past year.
MSBI had positive earnings in 4 of the past 5 years.
Of the past 5 years MSBI 4 years had a positive operating cash flow.
MSBI Yearly Net Income VS EBIT VS OCF VS FCFMSBI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M 500M

1.2 Ratios

The Return On Assets of MSBI (0.56%) is worse than 71.90% of its industry peers.
MSBI has a worse Return On Equity (5.32%) than 75.19% of its industry peers.
Industry RankSector Rank
ROA 0.56%
ROE 5.32%
ROIC N/A
ROA(3y)1.04%
ROA(5y)0.87%
ROE(3y)10.97%
ROE(5y)8.97%
ROIC(3y)N/A
ROIC(5y)N/A
MSBI Yearly ROA, ROE, ROICMSBI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2 4 6 8 10

1.3 Margins

Looking at the Profit Margin, with a value of 14.69%, MSBI is doing worse than 75.95% of the companies in the same industry.
MSBI's Profit Margin has improved in the last couple of years.
The Operating Margin and Gross Margin are not available for MSBI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) 14.69%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y36.3%
PM growth 5Y6.98%
GM growth 3YN/A
GM growth 5YN/A
MSBI Yearly Profit, Operating, Gross MarginsMSBI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 5 10 15 20 25

3

2. Health

2.1 Basic Checks

MSBI does not have a ROIC to compare to the WACC, probably because it is not profitable.
MSBI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
MSBI Yearly Shares OutstandingMSBI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M
MSBI Yearly Total Debt VS Total AssetsMSBI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2B 4B 6B

2.2 Solvency

The Debt to FCF ratio of MSBI is 0.92, which is an excellent value as it means it would take MSBI, only 0.92 years of fcf income to pay off all of its debts.
With a decent Debt to FCF ratio value of 0.92, MSBI is doing good in the industry, outperforming 74.43% of the companies in the same industry.
MSBI has a Debt/Equity ratio of 0.18. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of MSBI (0.18) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF 0.92
Altman-Z N/A
ROIC/WACCN/A
WACC15.83%
MSBI Yearly LT Debt VS Equity VS FCFMSBI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
MSBI Yearly Current Assets VS Current LiabilitesMSBI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M

2

3. Growth

3.1 Past

MSBI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -124.91%.
EPS 1Y (TTM)-124.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%7.55%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-5.76%

3.2 Future

Based on estimates for the next years, MSBI will show a very strong growth in Earnings Per Share. The EPS will grow by 140.43% on average per year.
The Revenue is expected to grow by 1.62% on average over the next years.
EPS Next Y461.86%
EPS Next 2Y140.43%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year2.4%
Revenue Next 2Y1.62%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

MSBI Yearly Revenue VS EstimatesMSBI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 100M 200M 300M
MSBI Yearly EPS VS EstimatesMSBI Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 1 2 3 4

6

4. Valuation

4.1 Price/Earnings Ratio

MSBI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
MSBI is valuated cheaply with a Price/Forward Earnings ratio of 6.40.
Compared to the rest of the industry, the Price/Forward Earnings ratio of MSBI indicates a rather cheap valuation: MSBI is cheaper than 91.90% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.20, MSBI is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 6.4
MSBI Price Earnings VS Forward Price EarningsMSBI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 -20

4.2 Price Multiples

MSBI's Price/Free Cash Flow ratio is rather cheap when compared to the industry. MSBI is cheaper than 98.73% of the companies in the same industry.
Industry RankSector Rank
P/FCF 2.28
EV/EBITDA N/A
MSBI Per share dataMSBI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

MSBI's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
MSBI's earnings are expected to grow with 140.43% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y140.43%
EPS Next 3YN/A

8

5. Dividend

5.1 Amount

MSBI has a Yearly Dividend Yield of 7.26%, which is a nice return.
MSBI's Dividend Yield is rather good when compared to the industry average which is at 3.45. MSBI pays more dividend than 97.22% of the companies in the same industry.
MSBI's Dividend Yield is rather good when compared to the S&P500 average which is at 2.40.
Industry RankSector Rank
Dividend Yield 7.26%

5.2 History

The dividend of MSBI is nicely growing with an annual growth rate of 11.38%!
MSBI has paid a dividend for at least 10 years, which is a reliable track record.
MSBI has not decreased its dividend in the past 5 years, so it has a somewhat stable track record.
Dividend Growth(5Y)11.38%
Div Incr Years8
Div Non Decr Years8
MSBI Yearly Dividends per shareMSBI Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

82.20% of the earnings are spent on dividend by MSBI. This is not a sustainable payout ratio.
MSBI's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP82.2%
EPS Next 2Y140.43%
EPS Next 3YN/A
MSBI Yearly Income VS Free CF VS DividendMSBI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M 500M
MSBI Dividend Payout.MSBI Dividend Payout, showing the Payout Ratio.MSBI Dividend Payout.PayoutRetained Earnings

MIDLAND STATES BANCORP INC

NASDAQ:MSBI (5/27/2025, 8:00:01 PM)

After market: 16.94 0 (0%)

16.94

-0.03 (-0.18%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)04-30 2025-04-30/amc
Earnings (Next)07-23 2025-07-23/amc
Inst Owners63.4%
Inst Owner Change2.79%
Ins Owners3.29%
Ins Owner Change0.27%
Market Cap364.21M
Analysts50
Price Target19.89 (17.41%)
Short Float %1.96%
Short Ratio3.28
Dividend
Industry RankSector Rank
Dividend Yield 7.26%
Yearly Dividend1.62
Dividend Growth(5Y)11.38%
DP82.2%
Div Incr Years8
Div Non Decr Years8
Ex-Date05-16 2025-05-16 (0.31)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-29.38%
Min EPS beat(2)-71.98%
Max EPS beat(2)13.22%
EPS beat(4)2
Avg EPS beat(4)-20.87%
Min EPS beat(4)-71.98%
Max EPS beat(4)13.22%
EPS beat(8)5
Avg EPS beat(8)-10.2%
EPS beat(12)9
Avg EPS beat(12)-4.91%
EPS beat(16)10
Avg EPS beat(16)-7.22%
Revenue beat(2)0
Avg Revenue beat(2)-2.52%
Min Revenue beat(2)-4.72%
Max Revenue beat(2)-0.32%
Revenue beat(4)2
Avg Revenue beat(4)-0.52%
Min Revenue beat(4)-4.72%
Max Revenue beat(4)2.06%
Revenue beat(8)3
Avg Revenue beat(8)1.19%
Revenue beat(12)4
Avg Revenue beat(12)0.82%
Revenue beat(16)4
Avg Revenue beat(16)-0.52%
PT rev (1m)-5.45%
PT rev (3m)-13.33%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 6.4
P/S 1.23
P/FCF 2.28
P/OCF 2.2
P/B 0.45
P/tB 0.58
EV/EBITDA N/A
EPS(TTM)-0.66
EYN/A
EPS(NY)2.65
Fwd EY15.62%
FCF(TTM)7.43
FCFY43.86%
OCF(TTM)7.7
OCFY45.46%
SpS13.77
BVpS38.06
TBVpS29.07
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.56%
ROE 5.32%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 14.69%
GM N/A
FCFM 53.96%
ROA(3y)1.04%
ROA(5y)0.87%
ROE(3y)10.97%
ROE(5y)8.97%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y36.3%
PM growth 5Y6.98%
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF 0.92
Debt/EBITDA N/A
Cap/Depr 49.76%
Cap/Sales 1.96%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 367.25%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score6
WACC15.83%
ROIC/WACCN/A
Cap/Depr(3y)41.75%
Cap/Depr(5y)34.79%
Cap/Sales(3y)1.64%
Cap/Sales(5y)1.6%
Profit Quality(3y)293.47%
Profit Quality(5y)814.22%
High Growth Momentum
Growth
EPS 1Y (TTM)-124.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%7.55%
EPS Next Y461.86%
EPS Next 2Y140.43%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-5.76%
Revenue Next Year2.4%
Revenue Next 2Y1.62%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-32.46%
FCF growth 3Y-33.52%
FCF growth 5Y10.17%
OCF growth 1Y-30.85%
OCF growth 3Y-32.33%
OCF growth 5Y9.75%